SCPS — Scopus Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value
Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq
Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq
Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule
Diagnostics, OppFi Inc
U.S. STOCKS ON THE MOVE-Icosavax, MEI Pharma, Clever Leaves
Scopus BioPharma slumps on Nasdaq deficiency notice
Brief: Scopus Biopharma Says Co Received Deficiency Notification Letters From Nasdaq
Brief: Scopus Biopharma Provides Update Following Annual Meeting Of Stockholders
Brief: Scopus Biopharma Files Prospectus Covers Offer And Resale By Selling Stockholders Of Up To 6 Mln Shares Of Co's Common Stock
Brief: Scopus Biopharma Issues Open Letter To Stockholders
Brief: Scopus Biopharma Sends Letter Urging Stockholders To Vote “For All” Of The Company’s Director Nominees On The White Proxy Card
Brief: Morris C. Laster - Urges Scopus Stockholders To Vote On Blue Proxy Card "For" Election Of Director Nominees, Mordechai Saar Hacham And Joshua Levine
U.S. STOCKS ON THE MOVE-Netflix, Chevron, American Airlines
Brief: Scopus Biopharma Announces Adjournment Of Annual Meeting Of Stockholders
Scopus BioPharma jumps after retaining counsel to probe share fall
Brief: Scopus Biopharma Retaining Counsel To Investigate Unusual Market Activity
Brief: Scopus Biopharma Says Delaware Court Of Chancery Approved A Stipulation Between Co, Morris Laster
Brief: Scopus Biopharma Unit Duet Therapeutics Releases Preclinical Data At 17Th Annual Meeting Of Oligonucleotide Therapeutics Society